Showing 1 - 8 of 8
Researcher wins medical scientist prize
News, Post Reporters, Published on 21/06/2023
» Krisana Kraisintu, a leading pharmaceutical researcher, has been named the medical scientist of the year for her globally renowned dedication to the development of antiretroviral and anti-malarial drugs, as well as herbal medicines which benefit not only Thais but also millions elsewhere.
House Speaker Chuan admitted to hospital after catching Covid
News, Post Reporters, Published on 13/07/2022
» House Speaker Chuan Leekpai has been admitted to Ramathibodi Hospital after testing positive for Covid-19, though his symptoms are mild for the time being, it was reported on Tuesday.
Hospital chases vaccine for booster shots
News, Post Reporters, Published on 17/10/2021
» Thammasat University Hospital (TUH) has decided to join a third-phase trial of a protein-based Covid-19 vaccine with a plan to import it for use as a booster shot early next year.
Senior execs cautiously optimistic
Business, Post Reporters, Published on 04/01/2021
» As the pandemic is set to continue ravaging economies across the globe in 2021, with higher infections at home and abroad, the time is ripe for business leaders to begin strategic adjustment and prepare contingency and long-term operational plans for survival and sustainability.
CPTPP could lead to 'soaring' health costs
News, Post Reporters, Published on 18/07/2020
» The Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) will cost Thailand considerably more in medicines and make the country further reliant on imported drugs while leaving state-owned drugmakers in a difficult position, according to a study by Chulalongkorn University.
FDA expands drug recall
News, Post Reporters, Published on 26/08/2018
» The Food and Drug Administration (FDA) has expanded its recall of valsartan, a medicine used to control blood pressure and help prevent heart failure, after some ingredients were found to contain an impurity.
Hep C meds urged for HIV patients
News, Post Reporters, Published on 28/07/2018
» Health networks have called on authorities to ensure patients with HIV/Aids have more access to medicine for the treatment of hepatitis C.
Hepatitis drug patent application opposed
News, Post Reporters, Published on 12/04/2017
» A health advocacy group voiced its opposition Tuesday to a patent application for hepatitis C medicine, Sofosbuvir, filed with the Department of Intellectual Property's Patent Office, which the group said was unjustified.